On 20 January 2025, the International Diabetes Federation (IDF) and the Institute for Medical and Nursing Education (IMNE) are co-organising the webinar, “It’s about timing and targeting: Practical guidance on implementation of once-weekly basal insulins,” targeted at endocrinologists, diabetologists and family medicine specialists.
While non-insulin therapies exist, many people living with diabetes will still need insulin therapy as type 2 diabetes (T2D) progresses.
This webinar covers:
- Guideline-based insulin initiation and titration.
- Current basal insulin benefits and limitations.
- Barriers to insulin therapy.
- Breakthrough findings on once-weekly basal insulins and their clinical impact.
Date and times: 20 January 2025, 09:30 (Mexico City) /12:30 (Brasilia) /16:30 (Copenhagen) / 19:30 (Dubai) / 22:30 (Mumbai)
Learning outcomes
Upon completion of this programme, the learner will be able to:
- Explain the adverse consequences of therapeutic inertia and related influence on patient outcomes, with a specific focus on the implications of delaying basal insulin therapy.
- Propose strategies to address barriers to the acceptance of insulin therapy among individuals with type 2 diabetes.
- Discuss data for once-weekly basal insulins and related potential impact on the management of people with type 2 diabetes.
- Develop and implement individualised basal insulin plans, including once-weekly basal insulins were appropriate, incorporating initiation, dosing, titration/intensification, and special circumstances.
Scientific Committee:
Prof. Tina Vilsbøll, Prof. Roopa Mehta
Speakers
- Prof. Tina Vilsbøll, University of Copenhagen
- Prof. Roopa Mehta, National Institute of Medical Sciences and Nutrition Salvador Zubirán of Mexico
- Dr. Hamed Farooqi, Dubai Diabetes Center
Programme
- Welcome, pre-test and introduction (10 mins) Prof. Tina Vilsbøll
- Is the current treatment paradigm improving outcomes for people with T2D? The role of basal insulin in modern T2D management (7 mins) Prof. Tina Vilsbøll
- Why is insulin uptake so low? Overcoming patient and physician barriers to insulin use (10 mins) Dr. Hamed Farooqi
- The emerging role of once-weekly insulins: How might these agents change the basal insulin landscape? (12 mins) Prof. Tina Vilsbøll
- Insights for the clinic: Practical guidance on effective use of basal insulin therapy (15 mins) Prof. Roopa Mehta
- Panel discussion and interactive question and answer session (15 mins) All
- Post-test and conclusions (6 mins) Prof. Tina Vilsbøll
CME Accreditation
An application was made to the EACCME for CME accreditation of this event. The EACCME is an institution of the UEMS (www.uems.eu).
Registration
Please be aware that health professionals from the U.K. and the U.S.A. are not eligible to join this webinar.
If you have any questions about the webinar, please contact [email protected]
This webinar is supported by an educational grant from Novo Nordisk A/S.